Highly Sensitive Cell-Based Assay To Detect The Presence Of Active Botulinum Neurotoxin Serotype-A

Patent No. EP3279335 (titled "Highly Sensitive Cell-Based Assay To Detect The Presence Of Active Botulinum Neurotoxin Serotype-A") was filed by Abel on Dec 28, 2012. The application was issued on Mar 10, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERZ PHARMADec 8, 2021ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3279335

ABEL
Application Number
EP17178062A
Filing Date
Dec 28, 2012
Status
Revoked
Aug 19, 2022
Publication Date
Mar 10, 2021